Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 5,230.00
+275.00 (5.55%)
Mar 20, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 321.86 billion as of March 20, 2026. Its market cap has decreased by -20.11% in one year.
Market Cap
321.86B
Enterprise Value
367.67B
Revenue
96.80B
Ranking
n/a
PE Ratio
21.99
Stock Price
5,230.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 321.86B, a decrease of -28.70%. That is a compound annual growth rate of -7.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 321.86B | 3.98% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seegene | 1.06T |
| WON TECH | 636.95B |
| Curexo | 625.80B |
| i-SENS | 586.47B |
| ToolGen | 433.83B |
| InBody Co.,Ltd | 362.11B |
| DRTECH | 155.85B |
| T&R Biofab | 144.61B |